Drug Diversion Insights with Terri Vidals

For everyone in the healthcare industry looking to reduce substance abuse and drug diversion. The host, Terri Vidals, is a pharmacist with over 30 years of experience; fifteen of those years in medication safety and drug diversion prevention and monitoring. Listen to an interview each week with a healthcare professional involved in diversion detection. Learn about how to leverage artificial intelligence to detect diversion and get exposure to products or services designed to facilitate diversion detection.

Drug Diversion Insights with Terri Vidals is a health podcast hosted by Terri Vidals, with 172 episodes on record and a Required Pod Score of 80. PitchCentric scores this show on Booking Probability, Listen Score, and live audience signals refreshed every 24 hours.

Terri Vidals hosts Drug Diversion Insights with Terri Vidals, a health show with 172 episodes published.

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

• 

  Drug Diversion Insights with Terri Vidals

  One Platform, Actionable Insight: A Comprehensive Approach to Diversion Management

  Sep 2, 202630 min

  A strong drug diversion program shouldn't just help you investigate what already happened. It should help you identify risk earlier and give your team the information needed to act. In this episode of Drug Diversion Insights , Rick Couldry, Chief Pharmacy and Clinical Officer at Omnicell, and Jay Patel, Product Manager for Diversion Management , join us to explore how healthcare organizations can move from reactive diversion investigations toward a more proactive, connected approach to diversion management. Drug diversion programs generate enormous amounts of data, but data alone doesn't create visibility. The challenge is connecting information across medication workflows, identifying meaningful patterns, and turning those patterns into actionable insights. Rick and Jay discuss what changes when diversion management becomes part of a broader medication-management ecosystem rather than operating as another isolated point solution. In this episode, we discuss: Why healthcare drug diversion remains difficult to detect proactively How connected medication data can strengthen diversion monitoring Turning diversion data into actionable insights The role of technology in supporting diversion investigations Why integration across medication-management workflows matters Omnicell's approach to Diversion Management How Diversion Management fits into Omnicell's broader medication-management strategy OmniSphere and the future of connected medication management The conversation also looks at OmniSphere , Omnicell's cloud-native platform, and what a more connected medication-management environment could mean for diversion teams. For healthcare organizations, the goal isn't simply to collect more data. It's to make that data more useful. Can connected systems provide the visibility needed to recognize potential diversion patterns sooner? Can analytics help teams focus limited investigative resources on the activity that matters most? And how can technology become part of a comprehensive diversion strategy that brings together people, processes, governance, and data? This episode is for pharmacy leaders, drug diversion specialists, medication safety professionals, compliance teams, nursing leaders, risk management professionals, healthcare executives, and health system technology leaders looking for ways to strengthen controlled substance oversight and move their diversion programs from reactive to proactive. Drug Diversion Insights is presented by Rxpert Solutions , bringing together healthcare leaders and industry experts to examine the challenges, strategies, and technologies shaping drug diversion prevention and medication safety.

  ListenShow Notes
• 

  Drug Diversion Insights with Terri Vidals

  Should Healthcare Professionals Be Allowed to Use Cannabis?

  Aug 26, 202644 min

  Cannabis laws are changing across the United States—but what should that mean for healthcare professionals working in safety-sensitive, patient-facing roles? In this episode of Drug Diversion Insights , Abby Migliore, COO of the Intervention Project for Nurses (IPN), and Shannon Opie, CEO , return to tackle one of the most complicated issues facing healthcare organizations today: cannabis, THC testing, workplace policy, impairment, and patient safety. Many healthcare facilities have strong drug diversion prevention and monitoring programs, yet cannabis is often treated differently. State laws vary widely, the federal regulatory landscape continues to evolve, and employers are left trying to determine how to create policies that are fair, defensible, and centered on safe patient care. Then there's the testing problem. Unlike alcohol, where testing can provide information about recent use and estimated alcohol concentration, a positive THC test does not necessarily establish whether a healthcare professional is impaired at that moment. THC metabolites may remain detectable after the impairing effects have passed, creating difficult questions for employers and monitoring programs. In this episode, we discuss: Why cannabis presents a unique challenge for healthcare workplace policies Medical versus recreational cannabis use among healthcare professionals The changing state and federal landscape surrounding marijuana How cannabis differs from alcohol in safety-sensitive workplaces Whether healthcare facilities should maintain cannabis-free workplace policies How organizations can balance employee considerations with their responsibility to protect patients The central issue isn't simply whether cannabis is legal. It's whether healthcare organizations have established a clear standard for professionals whose work directly affects the safety of patients. If an adverse event occurs and a healthcare professional subsequently tests positive for THC, determining whether cannabis contributed to the event may be difficult. But the absence of a clear policy can create uncertainty for everyone involved. What standard should healthcare adopt when the law, science, testing technology, and patient safety expectations don't align neatly? This episode doesn't pretend there is a simple answer. Instead, Abby and Shannon help unpack what we know, what we still don't know, and why healthcare organizations need to have this conversation before an incident forces them to. An important discussion for nurses, pharmacists, physicians, healthcare executives, HR leaders, compliance professionals, employee health teams, risk managers, diversion specialists, and anyone responsible for workplace drug and impairment policies. More from Rxpert Solutions

  ListenShow Notes
• 

  Drug Diversion Insights with Terri Vidals

  18% of Nurses Screened Positive. Why Are We Still Waiting?

  Aug 19, 202654 min

  Why do we so often wait until a nurse fails, an incident occurs, or patient safety is at risk before connecting someone with help? In this episode of Drug Diversion Insights , Terri is joined by Abby Migliore and Shannon Opie of the Intervention Project for Nurses (IPN) , Florida's alternative-to-discipline program for nurses with substance use disorders and other conditions that may affect safe practice. A national survey found that 18% of registered nurses screened positive for a substance use problem, with approximately one-third of those screening positive for a substance use disorder . Those findings raise an important question: Are we doing enough to recognize and support healthcare professionals before a problem reaches a crisis point? Abby and Shannon take us inside the alternative-to-discipline process and explain what structured recovery and return to nursing practice actually look like. In this episode, we discuss: How alternative-to-discipline programs for nurses work What happens when a nurse enters IPN Evaluation, treatment, and ongoing recovery monitoring Drug and alcohol testing requirements and testing cadence Workplace restrictions during return to practice The role of supervised return-to-work plans What neurocognitive testing evaluates before a nurse returns to practice Medications for opioid use disorder in safety-sensitive healthcare roles The balance between workplace accommodation and patient safety Why healthcare organizations often wait for a “smoking gun” before intervening The opportunity to recognize problems and connect nurses with support earlier Alternative-to-discipline doesn't mean eliminating accountability. It's about creating a structured pathway that supports recovery while keeping safe nursing practice and patient protection at the center. This conversation is especially relevant for nurses, nurse leaders, healthcare executives, employee health professionals, diversion specialists, compliance teams, professional monitoring programs, and anyone interested in substance use disorder among healthcare professionals. And there's more to come. Abby and Shannon will return for another conversation focused on cannabis in patient-facing healthcare roles, including the complicated question of cannabis-free workplace policies in states where cannabis is legal. Follow Drug Diversion Insights so you don't miss Part 2. More from Rxpert Solutions

  ListenShow Notes
• 

  Drug Diversion Insights with Terri Vidals

  The Safest Pharmacy Is the One That Talks About It

  Aug 14, 202647 min

  What happens when a pharmacy professional experiences a substance use disorder, enters recovery, and then returns to the same workplace—with the same colleagues and access to controlled substances? In this episode of Drug Diversion Insights , we hear both sides of that experience. One guest shares what it was like to return to pharmacy practice after substance use disorder and rebuild trust with colleagues. The other shares the perspective of the pharmacy leader responsible for maintaining the safeguards, accountability, and support needed to make that return safe for employees and patients alike. Together, they tackle a difficult question healthcare organizations often avoid: Can a healthcare professional in recovery safely return to a role with access to controlled substances? We discuss: What returning to pharmacy practice after substance use disorder really looks like The challenges of rebuilding trust with coworkers Accountability measures and safeguards that support a safe return to practice How pharmacy leaders can support recovery without compromising patient safety The role of state pharmacy recovery and professional monitoring programs Why transparency about recovery can be a strength How stigma can discourage healthcare professionals from seeking help Why open conversations about substance use disorder can strengthen workplace culture Whether having a professional in recovery on the team can actually increase awareness and accountability around controlled substances Supporting recovery and protecting patients don't have to be opposing goals. With appropriate monitoring, clear expectations, accountability, and a workplace willing to have honest conversations about substance use disorder, healthcare professionals can be supported while patient and medication safety remain the priority. This episode is for pharmacists, pharmacy technicians, pharmacy leaders, diversion specialists, compliance professionals, healthcare executives, and anyone interested in creating a safer and more supportive approach to substance use disorder in healthcare. Sometimes the safest pharmacy isn't the one where substance use disorder is never discussed. It's the one where people feel safe enough to talk about it. More from Rxpert Solutions

  ListenShow Notes
• 

  Drug Diversion Insights with Terri Vidals

  Upstream of Diversion: Pain, Mental Health, and the Making of a Substance Use Disorder

  Aug 5, 202659 min

  Substance use disorder rarely begins with the substance itself. Long before addiction develops, many individuals are navigating a complex combination of chronic pain, mental health challenges, trauma, and other life circumstances that increase their risk. Understanding those connections helps us recognize substance use disorder earlier and respond more effectively. In this episode of Drug Diversion Insights , Terri welcomes back Dr. Paul Lynch , anesthesiologist and CEO of US Pain Care, along with his father, Larry Lynch , a licensed clinical social worker. Together, they combine medical and behavioral health perspectives to explore why treating pain, mental health, and substance use disorder as separate conditions often falls short. In this episode, we discuss: The relationship between chronic pain and substance use disorder How mental health influences both pain and addiction The concept of the tri-diagnosis : pain, mental health, and substance use disorder Expanding to the quad-diagnosis , incorporating homelessness as another critical factor The challenge of determining whether pain or mental health issues come first Why integrated, whole-person care leads to better outcomes The importance of reducing stigma surrounding substance use disorder How earlier intervention can improve both patient care and long-term recovery Whether you're a physician, pharmacist, nurse, behavioral health professional, addiction specialist, healthcare leader, or simply interested in understanding the complexity of substance use disorder, this episode offers valuable insight into the factors that exist long before addiction becomes visible. By looking upstream, we can better understand the root causes of substance use disorder and create opportunities for earlier intervention, more compassionate care, and better outcomes for patients. More from Rxpert Solutions

  ListenShow Notes

Recent guests on Drug Diversion Insights with Terri Vidals. Study who booked and why before you pitch.

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.